Evonik stock trades at EUR 20.90, down 0.67% premarket
Published on 11/02/2026 at 08:06 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSBASF approach tests independent strategy
- Evonik's board rejected formal takeover talks with BASF after reviewing the potential offer.
- The company remains committed to developing its business independently while allowing a confidential exchange with BASF.
Evonik stock traded at EUR 20.90 on Lang & Schwarz at 08:04 CET on Monday, November 2, 2026, 0.67 percent below the Xetra close of Friday, October 30, 2026 at EUR 21.04. Investors can follow the real-time quote of Evonik stock.
Takeover pressure meets independence
Evonik's board rejected formal takeover talks with BASF after reviewing a letter expressing interest in a voluntary public offer, according to TradingView, citing dpa-AFX. The decision keeps Evonik on its existing strategic path and blocks formal negotiations at this stage.
The company remains willing to hold a confidential informational exchange. That channel would allow Evonik to explain its position and BASF to outline the commercial rationale behind its approach. For investors, the distinction between an exploratory exchange and formal negotiations keeps the potential transaction uncertain rather than turning it into an agreed deal.
The DAX market reports provide the broader backdrop for German equities: DAX market reports.
Further takeover developments and company updates are collected in More news and analyses on Evonik stock.
